Get the Stockscreener App
26.30
0.72%
-0.19
After Hours:
26.37
0.07
+0.27%
Overview
News
Price History
Option Chain
Financials
Why PFE Down?
Discussions
Forecast
Stock Split
Dividend History
Pfizer Inc stock is traded at $26.30, with a volume of 31.51M.
It is down -0.72% in the last 24 hours and down -0.49% over the past month.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
See More
Previous Close:
$26.49
Open:
$26.395
24h Volume:
31.51M
Relative Volume:
0.80
Market Cap:
$149.04B
Revenue:
$59.37B
Net Income/Loss:
$4.25B
P/E Ratio:
35.54
EPS:
0.74
Net Cash Flow:
$8.23B
1W Performance:
-1.57%
1M Performance:
-0.49%
6M Performance:
-12.42%
1Y Performance:
-6.57%
1-Day Range:
$26.22
$26.56
1-Week Range:
$25.96
$26.87
52-Week Range:
$24.48
$31.54
Pfizer Inc Stock (PFE) Company Profile
Name
Pfizer Inc
Sector
Industry
Phone
(212) 733-2323
Address
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Compare PFE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
26.30 | 149.04B | 59.37B | 4.25B | 8.23B | 0.74 |
|
LLY
Lilly Eli Co
|
725.72 | 689.73B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
78.69 | 349.44B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
147.03 | 344.63B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
171.56 | 303.17B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
97.92 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
Pfizer Inc Stock (PFE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Underperform |
| Oct-25-24 | Resumed | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Aug-07-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Mar-22-24 | Downgrade | Argus | Buy → Hold |
| Feb-23-24 | Initiated | Guggenheim | Buy |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Oct-20-23 | Resumed | UBS | Neutral |
| Oct-16-23 | Upgrade | Jefferies | Hold → Buy |
| Jul-17-23 | Reiterated | JP Morgan | Neutral |
| Jul-14-23 | Initiated | HSBC Securities | Buy |
| Jun-29-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-11-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Mar-06-23 | Initiated | Jefferies | Hold |
| Feb-07-23 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-26-23 | Downgrade | UBS | Buy → Neutral |
| Jan-17-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-04-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-05-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-03-22 | Reiterated | Bernstein | Mkt Perform |
| Dec-20-21 | Reiterated | Cowen | Outperform |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Upgrade | UBS | Neutral → Buy |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Nov-19-21 | Initiated | BMO Capital Markets | Outperform |
| Jul-27-21 | Resumed | Truist | Buy |
| May-06-21 | Downgrade | Mizuho | Buy → Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Feb-04-21 | Upgrade | DZ Bank | Hold → Buy |
| Dec-16-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-19-20 | Resumed | Goldman | Neutral |
| Nov-10-20 | Resumed | Bernstein | Mkt Perform |
| Oct-12-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Jun-16-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Feb-27-20 | Upgrade | Standpoint Research | Hold → Buy |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Jan-07-20 | Initiated | RBC Capital Mkts | Outperform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Jul-30-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-30-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-04-19 | Resumed | Morgan Stanley | Overweight |
| Feb-20-19 | Resumed | Citigroup | Neutral |
| Jan-31-19 | Upgrade | Argus | Hold → Buy |
| Jan-31-19 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-23-19 | Downgrade | UBS | Buy → Neutral |
| Dec-11-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-01-18 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
View All
Pfizer Inc Stock (PFE) Latest News
Is Pfizer Inc. (PFE) the Undervalued Defensive Stock for 2025? - Insider Monkey
Pain Management Therapeutics Market Is Expected To Reach Revenue Of USD 120.7 Bn By 2033, At 3.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock - Yahoo Finance
Baugh & Associates LLC Acquires 29,025 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
M.E. Allison & CO. Inc. Buys New Shares in Pfizer Inc. (NYSE:PFE) - MarketBeat
Public companies who have a significant stake must be disappointed along with institutions after Pfizer Limited's (NSE:PFIZER) market cap dropped by ₹14b - Simply Wall St
Brady Martz Wealth Solutions LLC Invests $1.52 Million in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Is Paying Out A Larger Dividend Than Last Year - Yahoo Finance
Pfizer Inc. (NYSE:PFE) Shares Acquired by Steigerwald Gordon & Koch Inc. - MarketBeat
Perkins Coie Trust Co Reduces Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Liberty One Investment Management LLC Increases Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Nexus Investment Management ULC Has $21.71 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Stock Price Down 0.6%Here's What Happened - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Brooklyn Investment Group - MarketBeat
Carnegie Investment Counsel Trims Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Why Pfizer (PFE) Is One of the Best Cheap Stocks to Buy for 2025? - Insider Monkey
Trust Co. of Vermont Has $8.58 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Verity & Verity LLC Sells 58,323 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Integrated Investment Consultants LLC Increases Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Arkadios Wealth Advisors Has $4.33 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by FARMERS & MERCHANTS TRUST Co OF LONG BEACH - MarketBeat
Whitener Capital Management Inc. Boosts Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
O Keefe Stevens Advisory Inc. Has $2.54 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Baker Chad R Lowers Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Somerset Trust Co Has $571,000 Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Purchased by Empirical Asset Management LLC - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Purchased by Park Avenue Securities LLC - MarketBeat
Pfizer (NYSE:PFE) Trading Down 0.3%Here's What Happened - MarketBeat
Pfizer Reduces Stake in Haleon through Share Sale - TipRanks
Pfizer Inc - Reuters
Avanza Fonder AB Takes Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Job Details Page - Pfizer
Woodstock Corp Lowers Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
RDA Financial Network Increases Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Drug Discovery Market Generated Opportunities, Future Scope by 2031 | Pfizer Inc., GlaxoSmithKline LLC, Merck - EIN News
In conversation at Veeva Summit: Jonathan Crowther, Pfizer - pharmaphorum
JPMorgan says Pfizer needs further pipeline progress to change current narrative - Yahoo Finance
Eagle Rock Investment Company LLC Reduces Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Certified Advisory Corp Has $1.89 Million Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Years-Old List of Alleged Pfizer COVID-19 Vaccine 'Side Effects' Is Misleading - Snopes.com
JGP Wealth Management LLC Has $933,000 Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Tallon Kerry Patrick Purchases Shares of 19,114 Pfizer Inc. (NYSE:PFE) - MarketBeat
Spinal Cord Injury Therapeutics Market Set to Witness Significant Growth by 2025-2032: ReNetX Bio, Inc, Pfizer - EIN News
Pfizer (NYSE:PFE) Trading Down 0.5%What's Next? - MarketBeat
Pfizer CEO At JPM Issues Clear Warning to Kennedy on Vaccines - MedCity News
Pfizer (NYSE:PFE) Shares Down 0.1%What's Next? - MarketBeat
Covid Cases Are Spiking. Is Pfizer Stock Now A Buy? - Investor's Business Daily
Beech Hill Advisors Inc. Sells 26,454 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Sells $700M Stake in Haleon, Trimming Ownership to 7.3% - Yahoo Finance
Pfizer Inc. (NYSE:PFE) Shares Sold by Smith Anglin Financial LLC - MarketBeat
Pfizer Inc Stock (PFE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.99%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):